The Emerging Role of Complement Proteins as a Target for Therapy of IgA NephropathyDana V. Rizk, Robert Wyatt|Frontiers in Immunology|2019Cited by 166
Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN StudyDana V. Rizk, Jonathan Barratt|Kidney International Reports|2023Cited by 59